NASDAQ: CPBI

Central Plains Bancshares, Inc.

CIK 0001979332 · Financials · SIC 6035 · Savings Institutions (Federal)

Mid by assets Assets $559M as of Aug 4, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (TEAD 10-Q) is open in full — no account needed.

8-K Filed Jul 30, 2026 · Period ending Jul 28, 2026

Summary not yet generated.

8-K Filed Jul 14, 2026 · Period ending Jul 8, 2026

CPBI subsidiary enters 3x severance change-in-control agreement with CFO Bradley Kool

2 material changes detected. Sign up free to read the summary.

Partner

Trade CPBI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jul 9, 2026 · Period ending Jul 8, 2026

Central Plains Bancshares appoints activist Stilwell Group nominee to board

3 material changes detected. Sign up free to read the summary.

10-K Filed Jun 18, 2026 · Period ending Mar 31, 2026

CPBI net income up 9.5% as loan growth accelerates to 11.5% and margin expands 24bp

5 material changes detected. Sign up free to read the summary.

10-Q Filed Feb 11, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 13, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

8-K Filed Aug 28, 2025 · Period ending Aug 26, 2025

Summary not yet generated.

10-Q Filed Aug 12, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

8-K Filed Jul 23, 2025 · Period ending Jul 22, 2025

Summary not yet generated.

10-K Filed Jun 26, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

8-K Filed May 5, 2025 · Period ending Apr 29, 2025

Summary not yet generated.

Latest financial statements

From 10-K filed Jun 18, 2026 (period ending Mar 31, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations

Description Year ended Mar 31, 2026 Year ended Mar 31, 2025 Year ended Mar 31, 2024
Operating expenses:
Interest expense 9.0 8.2 6.5
Income before income taxes 5.0 4.5 4.6
Income tax expense/(benefit) 1.0 0.9 0.9
Net income 4.0 3.7 3.8
Basic earnings per share 1.06 0.96 2.19
Diluted earnings per share 1.05 0.96 2.19

Consolidated Balance Sheets

Description Mar 31, 2026 Mar 31, 2025
Current assets:
Cash and equivalents 29.9 28.7
Property, plant and equipment, net 12.8 12.9
Deferred income taxes and other assets 2.2 2.7
TOTAL ASSETS 558.6 508.7
Current liabilities:
Total liabilities 469.7 425.4
Shareholders' equity:
Common stock 0.04 0.04
Capital in excess of stated value 39.7 39.3
Accumulated other comprehensive income (loss) (2.3) (3.6)
Retained earnings (deficit) 54.4 50.7
Total shareholders' equity 89.0 83.3
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 558.6 508.7

Consolidated Statements of Cash Flows

Description Year ended Mar 31, 2026 Year ended Mar 31, 2025
Operating Activities:
Net cash from operating activities 6.7 4.5
Investing Activities:
Net cash from investing activities (49.0) (27.9)
Financing Activities:
Net cash from financing activities 43.5 40.7

Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗

View AI report for this filing